📹In the final part of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel, highlights the importance of human oversight when using artificial intelligence to aid in decision making
appliedclinicaltrialsonline.com/view/the-role-…

Following a webinar on the use of a medical device in a migraine clinical trial, Florence Mowlem, PhD of ObvioHealth , caught up with ACT to discuss her biggest takeaways and what she is currently seeing in the digital trials space💬🗨️
appliedclinicaltrialsonline.com/view/managing-…

Improving Diversity in Clinical Trials (by Medidata)

Explore strategies to address diversity disparities in clinical trials and achieve regulatory compliance.

Learn More: ow.ly/Xhn750QYVsq

Improving the site-sponsor relationship can get trials off on the right foot and on a path for success🖋️ Kenny Kong, vice president of strategy, Veeva Systems Site Connect
appliedclinicaltrialsonline.com/view/focus-on-…

📹 In part 2 of this video interview with Editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel , discusses how #AI can be used in #clinicaltrials to streamline operational processes
appliedclinicaltrialsonline.com/view/integrati…

Spearheaded by disease foundations, the creation of clinical registries is streamlining data collection and driving informed decisions🖋️Yun Lu, PhD, Susan Li, Sarah Woody Lawrence, and Sowmya Kaur; all with Navitas LifeSciences
appliedclinicaltrialsonline.com/view/technolog…

Industry leaders discuss how technology can help companies adapt to the regulatory changes and accomplish their DE&I goals🖋️Rohit Nambisan, CEO and CoFounder,Lokavant appliedclinicaltrialsonline.com/view/new-legis…

Participants from: Javara @CircuitClinical Astellas Pharma US

A study conducted by the Tufts Center for the Study of Drug Development in collaboration with CluePoints and PwC revealed that slightly more than half of sponsors and contract research organizations have adopted risk-based quality management approaches
appliedclinicaltrialsonline.com/view/industry-…

📹In part 2 of this video interview, Tirisham Gyang, MD, assistant professor of neurology at The Ohio State University discusses how industry can effectively enroll patients from underrepresented populations into their trials
appliedclinicaltrialsonline.com/view/enhancing…

📹In part 1 of this video interview, Tirisham Gyang, MD, assistant professor of neurology at The Ohio State University discusses how new research is changing the way industry recognizes multiple sclerosis in non-white populations
appliedclinicaltrialsonline.com/view/recogniti…

While there is still potential left to be unlocked, current uses of artificial intelligence in clinical research include drug discovery, determining patient disposition, and dosing
appliedclinicaltrialsonline.com/view/examining…

Krazati (adagrasib) was previously granted accelerated approval by the U.S. FDA to treat patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer who were previously administered at least one systemic therapy
appliedclinicaltrialsonline.com/view/krazati-m…

Analysis assesses the relative percentage of quality issues detected via SDM that clinical study teams considered critical🖋️Steve Young, Sylviane de Viron, of CluePoints
appliedclinicaltrialsonline.com/view/a-review-…

Why weighing all of the ‘DE&I’ components is critical at site and sponsor levels🖋️Jamie Harper, MHA, CCRP, Vice President, Site Solutions and Engagement, WCG
appliedclinicaltrialsonline.com/view/diversity…

📹In the fourth and final part of this video interview, Alex Greg Sturmer, co-founder and CEO of Elysium Therapeutics, Inc. discusses the key features of O2P as well as plans for further development of the hydrocodone prodrug
appliedclinicaltrialsonline.com/view/how-does-…

Systematic review of over 800 retracted articles suggest that better identification of postretraction citations should be implemented.
appliedclinicaltrialsonline.com/view/how-often…

Improving Diversity in Clinical Trials (by Medidata)

Explore strategies to address diversity disparities in clinical trials and achieve regulatory compliance.

Learn More: ow.ly/Xhn750QYVsq

📹In part 2 of this video interview, Alex Greg Sturmer, co-founder and CEO of Elysium Therapeutics, Inc. discusses what industry should be keeping top of mind when it comes to designing and executing pain clinical studies
appliedclinicaltrialsonline.com/view/designing…

📹Alex Greg Sturmer, co-founder and CEO of Elysium Therapeutics, Inc. discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies
appliedclinicaltrialsonline.com/view/the-state…

Investigational, once-weekly combination shows promise as long-acting oral treatment option for those virologically suppressed with #HIV
appliedclinicaltrialsonline.com/view/results-f…